| ∧ ∨ Type | ∧ ∨ Title | Principal Investigators | Status | ∧ ∨ Year |
|---|---|---|---|---|
| INTLI - Finanziamenti internazionali |
Dissecting the molecular mechanism linking GCase-dependent lysosomal impairment with Parkinson’s disease
|
|
Ongoing | 2022 |
| FON_NAZ - Bandi Altre Fondazioni |
Exploiting innate lymphoid cells to predict clinical progression and response to therapy in myelodysplastic syndromes (1° anno)
|
|
Ongoing | 2022 |
| MIS - Bandi Ministero Salute |
Enhancement of the current hematopoietic stem cell-based gene therapy to broaden its accessibility to symptomatic patients affected by Metachromatic Leukodystrophy
|
|
Ongoing | 2021 |
| PRIN2020 - PRIN bando 2020 |
The link between metabolism and epigenetics in myocardial diseases
|
|
Ongoing | 2022 |
| ASS_NAZ - Bandi da Associazioni e altri Finanziatori privati nazionali |
Fluoxetine reveres cognitive defects in a mouse model of AT: a preclinical study to elucidate the precise mechanism of action
|
|
Ongoing | 2022 |
| Progetti PNRR - Young Researcher Seal of Excellence |
The sex-dependent effects of amino acid-based diets on energy metabolism: innovative approaches to manage the metabolic syndrome (THELMA)
|
|
Ongoing | 2022 |
| PRIN2020 - PRIN bando 2020 |
Multimodal Innovative THeranostic nanoSystem
|
|
Ongoing | 2022 |
| AL_RIC - Bandi da altri enti di ricerca |
Validazione di due nuovi trattamenti per la sindrome di Rett: focus sui difetti respiratori della malattia
|
|
Ongoing | 2022 |
| FON_NAZ - Bandi Altre Fondazioni |
All-optical fingerprinting of metastatic potential (5° anno)
|
|
Ongoing | 2023 |
| INTLI - Finanziamenti internazionali |
The lncRNA PHOX2B-AS1 in the pathogenesis and as potential drug target in Congenital Central Hypoventilation Syndrome (CCHS)
|
|
Ongoing | 2023 |
